Flowchart
| . | Patients, n . | Analysis set . |
|---|---|---|
| Randomized in HD15 before May 29, 2007 | 1788 | |
| Randomized not later than July 1, 2005 | 995 | |
| Qualified for HD15 | 962 | |
| Evaluable for outcome | 817 | HD15 analysis set (AS1) |
| PET performed and assessed by the panel | 355 | |
| Qualified for PET | 311 | PET analysis set (AS2) |
| 12-month follow-up after panel or event | 275 | NPV analysis set (AS3) |
| . | Patients, n . | Analysis set . |
|---|---|---|
| Randomized in HD15 before May 29, 2007 | 1788 | |
| Randomized not later than July 1, 2005 | 995 | |
| Qualified for HD15 | 962 | |
| Evaluable for outcome | 817 | HD15 analysis set (AS1) |
| PET performed and assessed by the panel | 355 | |
| Qualified for PET | 311 | PET analysis set (AS2) |
| 12-month follow-up after panel or event | 275 | NPV analysis set (AS3) |